Lassa fever vaccine (Inovio Pharmaceuticals)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLassa fever vaccine (Inovio Pharmaceuticals)
Drug Alias NameINO-4500
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLassa Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGhana
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals IncUS Army Medical Research Institute of Infectious Diseases
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals IncCoalition for Epidemic Preparedness Innovations
Inactive CompaniesN/A
Active IndicationsLassa Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A